The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
about
Breast dynamic contrast-enhanced examinations with fat suppression: are contrast-agent uptake curves affected by magnetic field inhomogeneity?Variations of dynamic contrast-enhanced magnetic resonance imaging in evaluation of breast cancer therapy response: a multicenter data analysis challengeImproved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data.Influence of B1-Inhomogeneity on Pharmacokinetic Modeling of Dynamic Contrast-Enhanced MRI: A Simulation StudyReview of treatment assessment using DCE-MRI in breast cancer radiation therapy.Transmit B1+ field inhomogeneity and T1 estimation errors in breast DCE-MRI at 3 tesla.The use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.Simultaneous T(1) and B(1) (+) mapping using reference region variable flip angle imaging.ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies.Pharmacokinetic mapping for lesion classification in dynamic breast MRI.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRIEvolution of multi-parametric MRI quantitative parameters following transrectal ultrasound-guided biopsy of the prostate.A linear algorithm of the reference region model for DCE-MRI is robust and relaxes requirements for temporal resolutionDifference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.Dynamic contrast-enhanced MRI for oncology drug development.Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results.Bloch-Siegert B1-Mapping Improves Accuracy and Precision of Longitudinal Relaxation Measurements in the Breast at 3 T.Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.The impact of reliable prebolus T 1 measurements or a fixed T 1 value in the assessment of glioma patients with dynamic contrast enhancing MRI.A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.Quantitative evaluation of dual-flip-angle T1 mapping on DCE-MRI kinetic parameter estimation in head and neck.Effects of flip angle uncertainty and noise on the accuracy of DCE-MRI metrics: comparison between standard concentration-based and signal difference methods.Effects of inflow and radiofrequency spoiling on the arterial input function in dynamic contrast-enhanced MRI: a combined phantom and simulation study.Uncertainty estimation in dynamic contrast-enhanced MRI.Analysis of parametric histogram from dynamic contrast-enhanced MRI: application in evaluating brain tumor response to radiotherapy.Evaluation of B1 inhomogeneity effect on DCE-MRI data analysis of brain tumor patients at 3T.B1 mapping for bias-correction in quantitative T1 imaging of the brain at 3T using standard pulse sequences.An efficient calculation method for pharmacokinetic parameters in brain permeability study using dynamic contrast-enhanced MRI.Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.Propagation of error from parameter constraints in quantitative MRI: Example application of multiple spin echo T2 mapping.Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value.Quantification techniques to minimize the effects of native T1 variation and B1 inhomogeneity in dynamic contrast-enhanced MRI of the breast at 3 T.Heuristic linear mapping of physiological parameters in dynamic contrast-enhanced MRI without T₁ measurement and contrast agent concentration.Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations.Dynamic contrast enhanced-MRI in head and neck cancer patients: variability of the precontrast longitudinal relaxation time (T10)
P2860
Q30581763-3A831A1E-3C18-4B38-BB95-81636346CDF4Q30810438-039DFE16-C387-4467-963D-70FC17BA2940Q31007807-16634FB6-84D7-44B8-B459-DE66267F6CFAQ33736299-908BB0C1-BAAC-44B8-830C-69E489213F34Q34367593-B7395C84-B1D2-494B-83A1-B3D80E3C5500Q34537722-1DDE1703-3994-4976-8BA6-8D048A5B8170Q34635573-A271316A-94C8-4CAB-9A3E-DB8BD8F542ECQ34940714-496397A5-AA2B-49DC-BB91-B2803FC6EA27Q35664458-49559C5E-3416-4419-B41A-B029B521F8A2Q36311542-C709EE1F-B6CD-4C9B-8D85-A08E07B201B1Q36501363-96A3134C-803F-42CE-9BD3-B57655CEA1ACQ36605752-0328F35E-BBBB-44F8-AF6D-E2DC9B1EDEABQ36803837-63622C7F-871A-4722-A072-BC9DBA3678D8Q38376846-E37B0192-5322-4C6A-905E-0E46C7824296Q38597048-64C14838-22F7-4928-A976-A37B025900AAQ38725827-2CDD4F8A-6F55-4B8A-BB2F-6A109054723DQ38989194-63A70EBB-8FC2-4D1F-9D5E-388C92F25303Q39043712-1BD22799-8708-4E8D-96B4-9AD7A3B74C82Q39262277-10E50B41-5C52-4ABA-A6C1-B19181BCEDE8Q39742586-E5D7DF3F-8137-47C2-82D6-AD602FC9A989Q40261840-B4C25F52-794E-4E10-A955-C8FF6E413354Q41331956-080A5E5B-6A9B-4438-993F-D0491EFF6D9FQ42450948-447CC73A-0EF7-4CA0-BC7F-A8C2209BB370Q43067918-45321D2B-69AD-4388-91BC-D34D75EAC67EQ43847693-393ED405-864F-48E3-A8A2-4B14CA146BD1Q45401985-8765D5AA-1A41-441A-8D18-ED62FD450F11Q45840193-F9A43D76-5047-4B7E-A610-E0D7FE07D567Q47291041-326AA5CE-FA61-4B33-BA32-F608B393F0F2Q47774437-47E8F6F9-022D-424F-80A9-F4E4E65B7A94Q48256960-98B642B9-54FB-4043-8E68-C1CCA8AA66F7Q48322318-C60DD08D-6164-4D71-A40B-D097700DB7B8Q48662497-47F438BB-D28F-4690-9FED-BD5F75265277Q49076621-0DE141FD-DB04-4E01-8511-0D80867DA5EBQ50144009-8217A9DB-E6E0-425C-95EC-76D2F274F48CQ51129136-BEEB8665-2928-485C-8913-A1F6925085DEQ51452634-A0D3EAA7-CA38-493E-A173-E83756795BDDQ51495591-584E9480-5333-4AC3-9725-C118EE023A73Q51563281-C3868906-0060-4DF8-855E-0892CD367008Q57154307-E355AD02-CEE6-454D-B46E-D3F8CE4A5DF2
P2860
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@en
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@nl
type
label
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@en
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@nl
prefLabel
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@en
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@nl
P2093
P356
P1476
The accuracy of pharmacokinetic parameter measurement in DCE-MRI of the breast at 3 T.
@en
P2093
P Di Giovanni
S I Semple
T S Ahearn
T W Redpath
P304
P356
10.1088/0031-9155/55/1/008
P577
2010-01-01T00:00:00Z